PD-L1 can be upregulated by tumor cell oncogenes [48–53] or by other mediators highly expressed within the tumor microenvironment (TME) such as tumor hypoxia [30], TLR-mediated signaling pathways [54], and IFNγ [55]. Here, IFNG is linked to neoplasm.